nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—MAOA—locus ceruleus—narcolepsy	0.0936	0.285	CbGeAlD
Naratriptan—HTR1F—forebrain—narcolepsy	0.0384	0.117	CbGeAlD
Naratriptan—HTR1B—brainstem—narcolepsy	0.0163	0.0496	CbGeAlD
Naratriptan—HTR1F—brain—narcolepsy	0.0159	0.0485	CbGeAlD
Naratriptan—HTR1D—brainstem—narcolepsy	0.0158	0.0481	CbGeAlD
Naratriptan—HTR1B—forebrain—narcolepsy	0.0157	0.0479	CbGeAlD
Naratriptan—HTR1B—Serotonin receptors—HTR2A—narcolepsy	0.0154	0.023	CbGpPWpGaD
Naratriptan—HTR1D—forebrain—narcolepsy	0.0152	0.0464	CbGeAlD
Naratriptan—HTR1A—brainstem—narcolepsy	0.0131	0.0401	CbGeAlD
Naratriptan—HTR1A—forebrain—narcolepsy	0.0127	0.0387	CbGeAlD
Naratriptan—MAOA—brainstem—narcolepsy	0.012	0.0366	CbGeAlD
Naratriptan—HTR1D—Amine ligand-binding receptors—HRH3—narcolepsy	0.0118	0.0176	CbGpPWpGaD
Naratriptan—HTR1A—Serotonin receptors—HTR2A—narcolepsy	0.0118	0.0175	CbGpPWpGaD
Naratriptan—HTR1B—Amine ligand-binding receptors—HRH3—narcolepsy	0.0116	0.0173	CbGpPWpGaD
Naratriptan—MAOA—forebrain—narcolepsy	0.0116	0.0353	CbGeAlD
Naratriptan—HTR1F—Monoamine GPCRs—HTR2A—narcolepsy	0.011	0.0163	CbGpPWpGaD
Naratriptan—HTR1B—midbrain—narcolepsy	0.0104	0.0316	CbGeAlD
Naratriptan—HTR1D—midbrain—narcolepsy	0.0101	0.0306	CbGeAlD
Naratriptan—HTR1F—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00923	0.0137	CbGpPWpGaD
Naratriptan—HTR1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.00883	0.0131	CbGpPWpGaD
Naratriptan—HTR1A—midbrain—narcolepsy	0.00838	0.0255	CbGeAlD
Naratriptan—MAOA—medulla oblongata—narcolepsy	0.00838	0.0255	CbGeAlD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00779	0.0116	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00779	0.0116	CbGpPWpGaD
Naratriptan—MAOA—midbrain—narcolepsy	0.00765	0.0233	CbGeAlD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00752	0.0112	CbGpPWpGaD
Naratriptan—HTR1D—Monoamine GPCRs—HTR2A—narcolepsy	0.00702	0.0105	CbGpPWpGaD
Naratriptan—HTR1B—Monoamine GPCRs—HTR2A—narcolepsy	0.00687	0.0102	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00667	0.00993	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00667	0.00993	CbGpPWpGaD
Naratriptan—HTR1B—brain—narcolepsy	0.00652	0.0199	CbGeAlD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00644	0.00959	CbGpPWpGaD
Naratriptan—HTR1D—brain—narcolepsy	0.00632	0.0192	CbGeAlD
Naratriptan—HTR1F—G alpha (i) signalling events—PENK—narcolepsy	0.00614	0.00914	CbGpPWpGaD
Naratriptan—HTR1D—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0059	0.00878	CbGpPWpGaD
Naratriptan—HTR1B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00578	0.0086	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00548	0.00816	CbGpPWpGaD
Naratriptan—HTR1A—brain—narcolepsy	0.00526	0.016	CbGeAlD
Naratriptan—HTR1A—Monoamine GPCRs—HTR2A—narcolepsy	0.00524	0.00779	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HCRTR2—narcolepsy	0.00508	0.00756	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HCRTR1—narcolepsy	0.00508	0.00756	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00498	0.00741	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00498	0.00741	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—P2RY11—narcolepsy	0.00491	0.0073	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00488	0.00727	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00488	0.00726	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00488	0.00726	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Other—HTR2A—narcolepsy	0.00488	0.00726	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00481	0.00716	CbGpPWpGaD
Naratriptan—MAOA—brain—narcolepsy	0.00481	0.0147	CbGeAlD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00471	0.00701	CbGpPWpGaD
Naratriptan—HTR1F—G alpha (i) signalling events—HRH3—narcolepsy	0.00458	0.00682	CbGpPWpGaD
Naratriptan—HTR1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0044	0.00655	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00427	0.00635	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00427	0.00635	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00425	0.00633	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00418	0.00622	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00418	0.00622	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HCRT—narcolepsy	0.00417	0.00621	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00415	0.00618	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00412	0.00613	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00404	0.00601	CbGpPWpGaD
Naratriptan—HTR1D—G alpha (i) signalling events—PENK—narcolepsy	0.00393	0.00585	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—PENK—narcolepsy	0.00385	0.00573	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—PENK—narcolepsy	0.00372	0.00554	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00372	0.00553	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00372	0.00553	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00364	0.00542	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00359	0.00534	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0035	0.00522	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00343	0.00511	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HCRTR1—narcolepsy	0.00325	0.00484	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HCRTR2—narcolepsy	0.00325	0.00484	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00318	0.00474	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00318	0.00474	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HCRTR2—narcolepsy	0.00318	0.00474	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HCRTR1—narcolepsy	0.00318	0.00474	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—TRH—narcolepsy	0.00316	0.00471	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—P2RY11—narcolepsy	0.00314	0.00467	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00312	0.00465	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00307	0.00458	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—P2RY11—narcolepsy	0.00307	0.00457	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00306	0.00455	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00302	0.00449	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00302	0.00449	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00296	0.0044	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—PENK—narcolepsy	0.00293	0.00436	CbGpPWpGaD
Naratriptan—HTR1D—G alpha (i) signalling events—HRH3—narcolepsy	0.00293	0.00436	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HCRTR2—narcolepsy	0.00287	0.00427	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HCRTR1—narcolepsy	0.00287	0.00427	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—HRH3—narcolepsy	0.00287	0.00427	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—P2RY11—narcolepsy	0.00277	0.00413	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HRH3—narcolepsy	0.00277	0.00413	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00272	0.00405	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HCRT—narcolepsy	0.00267	0.00397	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00266	0.00396	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00266	0.00395	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00261	0.00389	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HCRT—narcolepsy	0.00261	0.00389	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HCRTR1—narcolepsy	0.00261	0.00388	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HCRTR2—narcolepsy	0.00261	0.00388	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0026	0.00387	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—P2RY11—narcolepsy	0.00252	0.00375	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00251	0.00374	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00242	0.00361	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00242	0.00361	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—PENK—narcolepsy	0.00238	0.00354	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HCRT—narcolepsy	0.00236	0.00351	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—P2RY11—narcolepsy	0.00234	0.00348	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00233	0.00347	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—PENK—narcolepsy	0.00233	0.00347	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00233	0.00347	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—NPS—narcolepsy	0.0023	0.00342	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—TAC1—narcolepsy	0.0023	0.00342	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00228	0.00339	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—HRH3—narcolepsy	0.00218	0.00325	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HCRT—narcolepsy	0.00214	0.00319	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00212	0.00315	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—PENK—narcolepsy	0.0021	0.00313	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00203	0.00302	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—TRH—narcolepsy	0.00202	0.00301	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HCRT—narcolepsy	0.00199	0.00296	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00198	0.00295	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—TRH—narcolepsy	0.00198	0.00295	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00193	0.00287	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00193	0.00287	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PENK—narcolepsy	0.00191	0.00284	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00189	0.00281	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00189	0.00281	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00184	0.00273	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00184	0.00273	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00182	0.0027	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.0018	0.00268	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.0018	0.00268	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—TRH—narcolepsy	0.00179	0.00266	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00178	0.00265	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—PENK—narcolepsy	0.00177	0.00264	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00177	0.00264	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HRH3—narcolepsy	0.00177	0.00264	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00174	0.00259	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00174	0.00258	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HRH3—narcolepsy	0.00174	0.00258	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00167	0.00248	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00167	0.00248	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00163	0.00243	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00163	0.00243	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—TRH—narcolepsy	0.00162	0.00242	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—P2RY11—narcolepsy	0.00161	0.0024	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—P2RY11—narcolepsy	0.00158	0.00235	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HRH3—narcolepsy	0.00157	0.00233	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HCRTR1—narcolepsy	0.00154	0.00229	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HCRTR2—narcolepsy	0.00154	0.00229	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00151	0.00225	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—TRH—narcolepsy	0.00151	0.00225	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HCRT—narcolepsy	0.00151	0.00224	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—P2RY11—narcolepsy	0.00149	0.00221	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HCRT—narcolepsy	0.00148	0.0022	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—TAC1—narcolepsy	0.00147	0.00219	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—NPS—narcolepsy	0.00147	0.00219	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00144	0.00214	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00144	0.00214	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—NPS—narcolepsy	0.00144	0.00214	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—TAC1—narcolepsy	0.00144	0.00214	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HRH3—narcolepsy	0.00142	0.00212	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HTR2A—narcolepsy	0.00138	0.00206	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00137	0.00204	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00137	0.00204	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HCRT—narcolepsy	0.00137	0.00204	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00135	0.00202	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PENK—narcolepsy	0.00134	0.002	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HCRT—narcolepsy	0.00134	0.002	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00133	0.00197	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00132	0.00197	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HRH3—narcolepsy	0.00132	0.00197	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PENK—narcolepsy	0.00132	0.00196	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—TAC1—narcolepsy	0.0013	0.00193	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—NPS—narcolepsy	0.0013	0.00193	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HCRT—narcolepsy	0.00127	0.00188	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00124	0.00185	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00124	0.00185	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PENK—narcolepsy	0.00122	0.00182	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—P2RY11—narcolepsy	0.0012	0.00179	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PENK—narcolepsy	0.0012	0.00178	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—NPS—narcolepsy	0.00118	0.00176	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—TAC1—narcolepsy	0.00118	0.00176	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CHKB—narcolepsy	0.00117	0.00175	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00116	0.00173	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—TRH—narcolepsy	0.00114	0.0017	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00114	0.00169	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PENK—narcolepsy	0.00113	0.00168	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HCRT—narcolepsy	0.00112	0.00167	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—TRH—narcolepsy	0.00112	0.00167	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—NPS—narcolepsy	0.0011	0.00163	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—TAC1—narcolepsy	0.0011	0.00163	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TRH—narcolepsy	0.00104	0.00154	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HCRT—narcolepsy	0.00102	0.00152	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TRH—narcolepsy	0.00102	0.00151	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00101	0.0015	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PENK—narcolepsy	0.001	0.00149	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HRH3—narcolepsy	0.001	0.00149	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HCRTR2—narcolepsy	0.000985	0.00147	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HCRTR1—narcolepsy	0.000985	0.00147	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HRH3—narcolepsy	0.000981	0.00146	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HCRTR2—narcolepsy	0.000965	0.00144	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HCRTR1—narcolepsy	0.000965	0.00144	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TRH—narcolepsy	0.000959	0.00143	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—P2RY11—narcolepsy	0.000951	0.00142	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—P2RY11—narcolepsy	0.000932	0.00139	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PENK—narcolepsy	0.00091	0.00136	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HRH3—narcolepsy	0.00091	0.00135	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HRH3—narcolepsy	0.000891	0.00133	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HTR2A—narcolepsy	0.000884	0.00132	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000866	0.00129	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR2A—narcolepsy	0.000866	0.00129	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—TRH—narcolepsy	0.000852	0.00127	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HRH3—narcolepsy	0.000841	0.00125	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—NPS—narcolepsy	0.00083	0.00124	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—TAC1—narcolepsy	0.00083	0.00124	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—TAC1—narcolepsy	0.000813	0.00121	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—NPS—narcolepsy	0.000813	0.00121	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HCRT—narcolepsy	0.000809	0.0012	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CPT1B—narcolepsy	0.000798	0.00119	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HCRT—narcolepsy	0.000792	0.00118	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR2A—narcolepsy	0.000781	0.00116	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TRH—narcolepsy	0.000774	0.00115	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000765	0.00114	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—NPS—narcolepsy	0.000754	0.00112	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TAC1—narcolepsy	0.000754	0.00112	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HRH3—narcolepsy	0.000748	0.00111	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—NPS—narcolepsy	0.000738	0.0011	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TAC1—narcolepsy	0.000738	0.0011	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HCRTR1—narcolepsy	0.000735	0.00109	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HCRTR2—narcolepsy	0.000735	0.00109	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PENK—narcolepsy	0.000721	0.00107	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—P2RY11—narcolepsy	0.00071	0.00106	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR2A—narcolepsy	0.000709	0.00106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PENK—narcolepsy	0.000706	0.00105	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NPS—narcolepsy	0.000697	0.00104	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TAC1—narcolepsy	0.000697	0.00104	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HRH3—narcolepsy	0.000679	0.00101	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR2A—narcolepsy	0.000659	0.000981	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00065	0.000967	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—NPS—narcolepsy	0.000619	0.000922	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—TAC1—narcolepsy	0.000619	0.000922	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TRH—narcolepsy	0.000613	0.000913	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HCRT—narcolepsy	0.000603	0.000898	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TRH—narcolepsy	0.0006	0.000894	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TAC1—narcolepsy	0.000562	0.000837	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—NPS—narcolepsy	0.000562	0.000837	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PENK—narcolepsy	0.000538	0.000801	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HRH3—narcolepsy	0.000538	0.0008	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HRH3—narcolepsy	0.000526	0.000784	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2A—narcolepsy	0.0005	0.000744	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000489	0.000728	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TRH—narcolepsy	0.000457	0.000681	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2A—narcolepsy	0.000454	0.000675	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NPS—narcolepsy	0.000445	0.000663	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TAC1—narcolepsy	0.000445	0.000663	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2A—narcolepsy	0.000444	0.000661	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TAC1—narcolepsy	0.000436	0.000649	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NPS—narcolepsy	0.000436	0.000649	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2A—narcolepsy	0.000419	0.000624	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HRH3—narcolepsy	0.000401	0.000597	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000373	0.000555	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2A—narcolepsy	0.000338	0.000504	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NPS—narcolepsy	0.000332	0.000495	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TAC1—narcolepsy	0.000332	0.000495	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—narcolepsy	0.000268	0.000399	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—narcolepsy	0.000262	0.000391	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—narcolepsy	0.0002	0.000298	CbGpPWpGaD
